Shenzhenshi Xunxing Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhenshi Xunxing Trading Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include KINPER and CAZENTIA. The owner is based in Longgang, Shenzhen.

Jinzhou Jiali Garden, Yangmei Community

Room 403, 4th Floor, Building 6

Longgang, Shenzhen 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CAZENTIA
CAZENTIA
Registered 2024
KINPER
KINPER
Registered 2022

Trademark Classifications

Shenzhenshi Xunxing Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhenshi Xunxing Trading Co., Ltd. have?

Shenzhenshi Xunxing Trading Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shenzhenshi Xunxing Trading Co., Ltd. file in?

Shenzhenshi Xunxing Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhenshi Xunxing Trading Co., Ltd.'s most well-known trademarks?

Shenzhenshi Xunxing Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as KINPER and CAZENTIA. These are among 2 currently registered trademarks in the portfolio.

What is Shenzhenshi Xunxing Trading Co., Ltd.'s trademark registration success rate?

Shenzhenshi Xunxing Trading Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.